Logo image of COR

CENCORA INC (COR) Stock Fundamental Analysis

NYSE:COR - New York Stock Exchange, Inc. - US03073E1055 - Common Stock

245.19  +0.12 (+0.05%)

Fundamental Rating

6

Taking everything into account, COR scores 6 out of 10 in our fundamental rating. COR was compared to 108 industry peers in the Health Care Providers & Services industry. COR scores excellent on profitability, but there are some minor concerns on its financial health. COR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

COR had positive earnings in the past year.
COR had a positive operating cash flow in the past year.
Of the past 5 years COR 4 years were profitable.
Each year in the past 5 years COR had a positive operating cash flow.
COR Yearly Net Income VS EBIT VS OCF VS FCFCOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B

1.2 Ratios

COR has a Return On Assets of 2.25%. This is in the better half of the industry: COR outperforms 65.42% of its industry peers.
Looking at the Return On Equity, with a value of 233.63%, COR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
COR's Return On Invested Capital of 18.49% is amongst the best of the industry. COR outperforms 93.46% of its industry peers.
COR had an Average Return On Invested Capital over the past 3 years of 16.51%. This is significantly above the industry average of 8.27%.
The last Return On Invested Capital (18.49%) for COR is above the 3 year average (16.51%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.25%
ROE 233.63%
ROIC 18.49%
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
COR Yearly ROA, ROE, ROICCOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

COR has a Profit Margin of 0.51%. This is comparable to the rest of the industry: COR outperforms 56.07% of its industry peers.
In the last couple of years the Profit Margin of COR has grown nicely.
Looking at the Operating Margin, with a value of 1.03%, COR is in line with its industry, outperforming 43.93% of the companies in the same industry.
In the last couple of years the Operating Margin of COR has remained more or less at the same level.
Looking at the Gross Margin, with a value of 3.33%, COR is doing worse than 83.18% of the companies in the same industry.
COR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.03%
PM (TTM) 0.51%
GM 3.33%
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
COR Yearly Profit, Operating, Gross MarginsCOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 -1 2 3

6

2. Health

2.1 Basic Checks

COR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for COR has been reduced compared to 1 year ago.
The number of shares outstanding for COR has been reduced compared to 5 years ago.
COR has a better debt/assets ratio than last year.
COR Yearly Shares OutstandingCOR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
COR Yearly Total Debt VS Total AssetsCOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

An Altman-Z score of 4.95 indicates that COR is not in any danger for bankruptcy at the moment.
COR has a better Altman-Z score (4.95) than 85.98% of its industry peers.
The Debt to FCF ratio of COR is 1.46, which is an excellent value as it means it would take COR, only 1.46 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.46, COR belongs to the top of the industry, outperforming 88.78% of the companies in the same industry.
COR has a Debt/Equity ratio of 5.90. This is a high value indicating a heavy dependency on external financing.
COR has a worse Debt to Equity ratio (5.90) than 85.05% of its industry peers.
Even though the debt/equity ratio score it not favorable for COR, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 5.9
Debt/FCF 1.46
Altman-Z 4.95
ROIC/WACC2.1
WACC8.81%
COR Yearly LT Debt VS Equity VS FCFCOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

COR has a Current Ratio of 0.88. This is a bad value and indicates that COR is not financially healthy enough and could expect problems in meeting its short term obligations.
COR has a worse Current ratio (0.88) than 81.31% of its industry peers.
A Quick Ratio of 0.53 indicates that COR may have some problems paying its short term obligations.
With a Quick ratio value of 0.53, COR is not doing good in the industry: 86.92% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.53
COR Yearly Current Assets VS Current LiabilitesCOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

5

3. Growth

3.1 Past

COR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.76%, which is quite good.
The Earnings Per Share has been growing by 14.21% on average over the past years. This is quite good.
The Revenue has grown by 12.12% in the past year. This is quite good.
COR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.36% yearly.
EPS 1Y (TTM)14.76%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%16.78%
Revenue 1Y (TTM)12.12%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%14.69%

3.2 Future

COR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.76% yearly.
The Revenue is expected to grow by 7.34% on average over the next years.
EPS Next Y9.8%
EPS Next 2Y9.4%
EPS Next 3Y9.14%
EPS Next 5Y10.76%
Revenue Next Year9.38%
Revenue Next 2Y7.91%
Revenue Next 3Y7.44%
Revenue Next 5Y7.34%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COR Yearly Revenue VS EstimatesCOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 100B 200B 300B 400B
COR Yearly EPS VS EstimatesCOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 17.82, the valuation of COR can be described as rather expensive.
Based on the Price/Earnings ratio, COR is valued a bit cheaper than 74.77% of the companies in the same industry.
COR is valuated rather cheaply when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 16.23, which indicates a correct valuation of COR.
Compared to the rest of the industry, the Price/Forward Earnings ratio of COR indicates a somewhat cheap valuation: COR is cheaper than 73.83% of the companies listed in the same industry.
COR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.82
Fwd PE 16.23
COR Price Earnings VS Forward Price EarningsCOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, COR is valued a bit cheaper than 68.22% of the companies in the same industry.
COR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. COR is cheaper than 82.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.81
EV/EBITDA 11.69
COR Per share dataCOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates COR does not grow enough to justify the current Price/Earnings ratio.
COR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.82
PEG (5Y)1.25
EPS Next 2Y9.4%
EPS Next 3Y9.14%

5

5. Dividend

5.1 Amount

COR has a yearly dividend return of 0.91%, which is pretty low.
Compared to an average industry Dividend Yield of 2.87, COR pays a better dividend. On top of this COR pays more dividend than 82.24% of the companies listed in the same industry.
With a Dividend Yield of 0.91, COR pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.91%

5.2 History

The dividend of COR has a limited annual growth rate of 5.42%.
COR has paid a dividend for at least 10 years, which is a reliable track record.
COR has decreased its dividend in the last 3 years.
Dividend Growth(5Y)5.42%
Div Incr Years2
Div Non Decr Years2
COR Yearly Dividends per shareCOR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

5.3 Sustainability

27.58% of the earnings are spent on dividend by COR. This is a low number and sustainable payout ratio.
COR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP27.58%
EPS Next 2Y9.4%
EPS Next 3Y9.14%
COR Yearly Income VS Free CF VS DividendCOR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B
COR Dividend Payout.COR Dividend Payout, showing the Payout Ratio.COR Dividend Payout.PayoutRetained Earnings

CENCORA INC

NYSE:COR (1/22/2025, 10:36:08 AM)

245.19

+0.12 (+0.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)02-05 2025-02-05/amc
Inst Owners89.98%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change9.23%
Market Cap47.39B
Analysts77.27
Price Target277.45 (13.16%)
Short Float %4.55%
Short Ratio6.36
Dividend
Industry RankSector Rank
Dividend Yield 0.91%
Yearly Dividend2.1
Dividend Growth(5Y)5.42%
DP27.58%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.73%
Min EPS beat(2)2.68%
Max EPS beat(2)2.79%
EPS beat(4)4
Avg EPS beat(4)4.92%
Min EPS beat(4)1.86%
Max EPS beat(4)12.33%
EPS beat(8)8
Avg EPS beat(8)3.8%
EPS beat(12)11
Avg EPS beat(12)3.32%
EPS beat(16)15
Avg EPS beat(16)3.55%
Revenue beat(2)2
Avg Revenue beat(2)0.42%
Min Revenue beat(2)0.04%
Max Revenue beat(2)0.79%
Revenue beat(4)3
Avg Revenue beat(4)0.03%
Min Revenue beat(4)-4.13%
Max Revenue beat(4)3.42%
Revenue beat(8)6
Avg Revenue beat(8)1.28%
Revenue beat(12)8
Avg Revenue beat(12)0.85%
Revenue beat(16)11
Avg Revenue beat(16)0.83%
PT rev (1m)0.82%
PT rev (3m)4.17%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.46%
EPS NY rev (1m)0%
EPS NY rev (3m)0.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.95%
Revenue NY rev (1m)0.8%
Revenue NY rev (3m)2.25%
Valuation
Industry RankSector Rank
PE 17.82
Fwd PE 16.23
P/S 0.16
P/FCF 15.81
P/OCF 13.6
P/B 73.37
P/tB N/A
EV/EBITDA 11.69
EPS(TTM)13.76
EY5.61%
EPS(NY)15.11
Fwd EY6.16%
FCF(TTM)15.51
FCFY6.33%
OCF(TTM)18.03
OCFY7.35%
SpS1520.9
BVpS3.34
TBVpS-65.57
PEG (NY)1.82
PEG (5Y)1.25
Profitability
Industry RankSector Rank
ROA 2.25%
ROE 233.63%
ROCE 23.71%
ROIC 18.49%
ROICexc 24.47%
ROICexgc N/A
OM 1.03%
PM (TTM) 0.51%
GM 3.33%
FCFM 1.02%
ROA(3y)2.68%
ROA(5y)0.61%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)16.51%
ROIC(5y)15.55%
ROICexc(3y)21.56%
ROICexc(5y)21.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.17%
ROCE(5y)19.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.26%
ROICexc growth 5Y0.87%
OM growth 3Y-6.12%
OM growth 5Y-0.1%
PM growth 3Y-10.65%
PM growth 5Y1.52%
GM growth 3Y1.72%
GM growth 5Y3.69%
F-Score7
Asset Turnover4.38
Health
Industry RankSector Rank
Debt/Equity 5.9
Debt/FCF 1.46
Debt/EBITDA 0.92
Cap/Depr 43.54%
Cap/Sales 0.17%
Interest Coverage 12.16
Cash Conversion 83.79%
Profit Quality 198.63%
Current Ratio 0.88
Quick Ratio 0.53
Altman-Z 4.95
F-Score7
WACC8.81%
ROIC/WACC2.1
Cap/Depr(3y)53.4%
Cap/Depr(5y)67.19%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.19%
Profit Quality(3y)175.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.76%
EPS 3Y14.11%
EPS 5Y14.21%
EPS Q2Q%16.78%
EPS Next Y9.8%
EPS Next 2Y9.4%
EPS Next 3Y9.14%
EPS Next 5Y10.76%
Revenue 1Y (TTM)12.12%
Revenue growth 3Y11.16%
Revenue growth 5Y10.36%
Sales Q2Q%14.69%
Revenue Next Year9.38%
Revenue Next 2Y7.91%
Revenue Next 3Y7.44%
Revenue Next 5Y7.34%
EBIT growth 1Y19.97%
EBIT growth 3Y4.36%
EBIT growth 5Y10.24%
EBIT Next Year28.04%
EBIT Next 3Y13.74%
EBIT Next 5Y5.18%
FCF growth 1Y-13.19%
FCF growth 3Y10.42%
FCF growth 5Y8.07%
OCF growth 1Y-10.91%
OCF growth 3Y9.35%
OCF growth 5Y8.25%